Your institution may have access to this item. Find your institution then sign in to continue.
Title
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: New considerations for the management of patients with tetanus-prone injuries